cholestyramine resin has been researched along with Insulin Sensitivity in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anderson, D; Benson, B; Brown, R; Bullard, S; Chen, L; Collins, J; Grimes, A; Handlon, AL; Klein, R; Kleymenova, E; Krull, D; Liu, Y; McNulty, J; Murray, D; Nystrom, C; Remlinger, K; Yao, X; Young, A | 1 |
Arita, E; Auwerx, J; Horai, Y; Houten, SM; Itoh, H; Kaneko-Iwasaki, N; Mataki, C; Morimoto, K; Murahashi, K; Sato, H; Schoonjans, K; Sugizaki, T; Suzuki, T; Watanabe, M | 1 |
Babaya, N; Fujisawa, T; Hiromine, Y; Ikegami, H; Itoi-Babaya, M; Kawabata, Y; Kobayashi, M; Nojima, K; Noso, S; Ogihara, T; Shibata, M; Yamaji, K | 1 |
3 other study(ies) available for cholestyramine resin and Insulin Sensitivity
Article | Year |
---|---|
Cholestyramine reverses hyperglycemia and enhances glucose-stimulated glucagon-like peptide 1 release in Zucker diabetic fatty rats.
Topics: Animals; Blood Glucose; Cholestyramine Resin; Diabetes Mellitus, Experimental; Gene Expression; Glucagon-Like Peptide 1; Glucose Tolerance Test; Glycated Hemoglobin; Hypoglycemic Agents; Insulin; Insulin Resistance; Intestinal Mucosa; Liver; Liver X Receptors; Male; Obesity; Orphan Nuclear Receptors; Peptide YY; Rats; Rats, Zucker; Receptors, Cytoplasmic and Nuclear | 2010 |
Bile acid binding resin improves metabolic control through the induction of energy expenditure.
Topics: Animals; Bile Acids and Salts; Cholesterol; Cholestyramine Resin; Energy Metabolism; Epichlorohydrin; Glucose; Glucose Tolerance Test; Imidazoles; Insulin Resistance; Male; Metabolic Syndrome; Mice; Mice, Inbred C57BL; Mice, Transgenic; Models, Biological; Protein Binding; Receptors, G-Protein-Coupled; Resins, Synthetic; Signal Transduction | 2012 |
Prevention and treatment of obesity, insulin resistance, and diabetes by bile acid-binding resin.
Topics: Adipose Tissue; Animals; Anticholesteremic Agents; Blood Glucose; Body Weight; Carrier Proteins; Cholestyramine Resin; Diabetes Mellitus, Type 2; Disease Models, Animal; Epichlorohydrin; Fasting; Fatty Liver; Humans; Hyperlipidemias; Imidazoles; Insulin Resistance; Membrane Glycoproteins; Mice; Obesity; Resins, Synthetic; Weight Gain | 2007 |